Valuation: Danaher Corporation

Market Cap 16TCr 15TCr 13TCr 12TCr 23TCr 15,22700Cr 24TCr 1,60000Cr 64TCr 8,12500Cr 61TCr 59TCr 25,65000Cr P/E 2026 *
36.6x
P/E 2027 * 30.6x
Enterprise Value 18TCr 16TCr 15TCr 14TCr 26TCr 17,16200Cr 27TCr 1,80400Cr 72TCr 9,15700Cr 69TCr 67TCr 28,90800Cr EV / Sales 2026 *
6.95x
EV / Sales 2027 * 6.3x
Free-Float
70.57%
Yield 2026 *
0.63%
Yield 2027 * 0.69%
1 day+1.73%
1 week-0.85%
Current month-0.85%
1 month+5.88%
3 months+12.45%
6 months+34.52%
Current year+0.58%
1 week 222.96
Extreme 222.96
238.45
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
09/10/26 Other

Director

2,05,860 0.0293%
09/10/26 Issuer sale

Founder

-5,00,000 0.0711%
09/10/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%-0.85%+9.67%+16.99% 16TCr
+2.63%-0.32%+21.37%+52.93% 26TCr
-3.36%+4.81%-19.14%+62.92% 16TCr
-4.23%+1.83%-57.26%-17.96% 6.2TCr
+1.31%+11.01%+22.48%+54.20% 5.87TCr
-2.40%+0.30%+0.39%-9.93% 5.54TCr
+1.73%-0.06%+19.09%+59.76% 4.93TCr
-2.05%-2.95%+3.01%+56.46% 4.92TCr
+1.00%-1.11%+23.11%+78.88% 4.5TCr
-1.64%+7.59%+12.77%+17.70% 3.72TCr
Average -0.12%+2.41%+3.55%+37.19% 9.33TCr
Weighted average by Cap. -0.05%+1.72%+4.78%+40.40%

Financials

2026 *2027 *
Net sales 2.63TCr 2.36TCr 2.15TCr 1.96TCr 3.7TCr 2,46900Cr 3.82TCr 26TCr 10TCr 1,31700Cr 9.86TCr 9.65TCr 4,15800Cr 2.83TCr 2.54TCr 2.32TCr 2.12TCr 3.99TCr 2,65900Cr 4.11TCr 28TCr 11TCr 1,41900Cr 11TCr 10TCr 4,47800Cr
Net income 439.63Cr 394.31Cr 360.36Cr 328.95Cr 619.78Cr 41TCr 639.31Cr 4.34TCr 1.73TCr 22TCr 1.65TCr 1.61TCr 70TCr 521.52Cr 467.75Cr 427.48Cr 390.23Cr 735.22Cr 49TCr 758.39Cr 5.15TCr 2.05TCr 26TCr 1.96TCr 1.92TCr 83TCr
Net Debt 2.06TCr 1.85TCr 1.69TCr 1.54TCr 2.9TCr 1,93400Cr 2.99TCr 20TCr 8.11TCr 1,03200Cr 7.72TCr 7.56TCr 3,25800Cr 1.61TCr 1.44TCr 1.32TCr 1.2TCr 2.27TCr 1,51200Cr 2.34TCr 16TCr 6.34TCr 81TCr 6.04TCr 5.91TCr 2,54700Cr
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
06/26/06 $230.25 +1.73% 40,61,071
05/26/05 $226.34 -3.66% 51,38,041
04/26/04 $234.93 +2.09% 30,55,473
03/26/03 $230.11 +0.94% 26,88,094
02/26/02 $227.97 -1.83% 31,62,025
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
230.25USD
Average target price
259.90USD
Spread / Average Target
+12.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Danaher Corporation